Two non-invasive neuromodulation technologies — transcutaneous vagus nerve stimulation (tVNS) and transcutaneous spinal cord stimulation (tSCS) — are reshaping how we think about neurological rehabilitation.

Although they target different levels of the nervous system, these modalities share a surprising number of fundamental principles. Understanding these parallels gives clinicians, patients, and carers a clearer picture of how modern neuromodulation works, what to expect from treatment, and why these technologies represent a genuine shift from compensatory to restorative rehabilitation.

This article identifies ten fundamental parallels between tVNS and tSCS, drawing on the published scientific evidence to explore what they have in common, where they differ, and what this means for clinical practice.

Transcutaneous spinal cord stimulation (tSCS) represents a promising noninvasive neuromodulation technique for rehabilitation in spinal cord injury (SCI) and other neurological conditions.

From this article you will gain a clear understanding of how tSCS is used as a priming tool within rehabilitation, the research principles that guide its clinical application, how it is integrated alongside task-specific therapy, and what types of functional improvements and neuroplastic changes clinicians aim to achieve when it is delivered consistently over time.

Goal setting in rehabilitation can be particularly difficult. Clients understandably want to know: “How soon can I see the benefits of a particular intervention?” The benefit can be perceived in two ways: the extent of relief provided and the duration of the relief.

As a product and service provider, it's important to us that we manage expectations. That we don't over-promise and under-deliver, and for that reason, we work with medical devices that have at least some research guidance on expected results. Even in the best cases, there will there be individual variations in how someone responds to an intervention.

Transcutaneous spinal cord stimulation (tSCS) represents a promising noninvasive neuromodulation technique for rehabilitation in spinal cord injury (SCI) and other neurological conditions such as multiple sclerosis (MS).

This article examines three distinct therapeutic applications—spasticity, pain, and functional recovery—each with different treatment requirements and expected outcomes. In basic terms, we review how long treatment should last before beneficial effects emerge and, once they do, how long they will last.

Spasticity is common after spinal cord injury, and while medication can help, it isn’t always the best or only option. This article explores alternative ways to manage spasticity when medication isn’t effective or suitable. It looks at why symptoms can vary, what triggers may make spasticity worse, and the importance of an individualised approach. From rehabilitation strategies to practical day-to-day management, it provides a helpful overview for improving comfort, function, and quality of life.

Transcutaneous spinal cord stimulation (TSCS) is an emerging technique gaining interest in neurorehabilitation, but its origins go back further than many people realise. This article explores how TSCS developed, the early ideas and research that helped shape it, and why it has become an important area of focus today. A helpful overview for anyone looking to understand where TSCS came from and how it has evolved into the approach being explored in modern clinical practice.

This article provides an overview of transcutaneous spinal cord stimulation (tSCS), a non-invasive spinal stimulation therapy used in neurorehabilitation to support spasticity reduction, neuropathic pain management, and rehabilitation alongside therapy. It explains how tSCS works, reviews current research evidence, outlines safety considerations, and explores the growing availability of commercial tSCS devices for clinical and home-based use.